Acumen Pharmaceuticals, Inc. (ABOS)
0.2423
+0.02
(+8.41%)
USD |
NASDAQ |
Nov 09, 11:35
Acumen Pharmaceuticals Price : 0.2423 for Nov. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 0.2121 | 0.2274 | 0.2121 | 0.2235 | 2.006M |
| Nov 05, 2026 | 0.2162 | 0.2199 | 0.1911 | 0.2138 | 6.173M |
| Nov 04, 2026 | 0.23 | 0.2496 | 0.2163 | 0.2163 | 8.679M |
| Nov 03, 2026 | 0.2397 | 0.2481 | 0.225 | 0.2344 | 6.164M |
| Nov 02, 2026 | 0.2006 | 0.2668 | 0.198 | 0.2397 | 33.72M |
| Oct 30, 2026 | 0.3444 | 0.352 | 0.2092 | 0.2101 | 68.10M |
| Oct 29, 2026 | 2.40 | 2.52 | 2.285 | 2.29 | 808044.0 |
| Oct 28, 2026 | 2.28 | 2.495 | 2.257 | 2.38 | 1.408M |
| Oct 27, 2026 | 2.25 | 2.370 | 2.10 | 2.26 | 1.798M |
| Oct 26, 2026 | 2.13 | 2.42 | 1.97 | 2.27 | 1.650M |
| Oct 23, 2026 | 2.05 | 2.05 | 1.895 | 1.98 | 541794.0 |
| Oct 22, 2026 | 2.03 | 2.14 | 2.01 | 2.06 | 569491.0 |
| Oct 21, 2026 | 2.00 | 2.08 | 1.99 | 2.03 | 397706.0 |
| Oct 20, 2026 | 1.78 | 2.070 | 1.764 | 2.015 | 784618.0 |
| Oct 19, 2026 | 1.70 | 1.78 | 1.67 | 1.77 | 274684.0 |
| Oct 16, 2026 | 1.67 | 1.715 | 1.62 | 1.69 | 449342.0 |
| Oct 15, 2026 | 1.71 | 1.755 | 1.66 | 1.67 | 602707.0 |
| Oct 14, 2026 | 1.81 | 1.87 | 1.71 | 1.745 | 620856.0 |
| Oct 13, 2026 | 2.00 | 2.00 | 1.81 | 1.815 | 646336.0 |
| Oct 12, 2026 | 2.14 | 2.14 | 2.00 | 2.02 | 291649.0 |
| Oct 09, 2026 | 2.12 | 2.17 | 2.081 | 2.14 | 357544.0 |
| Oct 08, 2026 | 2.09 | 2.135 | 2.020 | 2.10 | 505169.0 |
| Oct 07, 2026 | 2.02 | 2.17 | 2.00 | 2.10 | 623092.0 |
| Oct 06, 2026 | 2.13 | 2.14 | 2.00 | 2.03 | 562869.0 |
| Oct 05, 2026 | 2.04 | 2.16 | 2.015 | 2.13 | 713980.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 21.40 |
| Alnylam Pharmaceuticals, Inc. | 156.05 |
| Anika Therapeutics, Inc. | 14.55 |
| Savara, Inc. | 4.955 |
| Vericel Corp. | 57.62 |
Price Related Metrics
| Price to Book Value | 0.5064 |
| Earnings Yield | -638.3% |
| Market Cap | 17.52M |